Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparative study of neurocognitively impaired patients receiving protease inhibitor monotherapy or triple-drug antiretroviral therapy.
Estébanez M, Stella-Ascariz N, Mingorance J, Pérez-Valero I, González-Baeza A, Bayón C, Lakatos B, Borobia A, Arnalich F, Arribas JR. Estébanez M, et al. Among authors: lakatos b. J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):419-23. doi: 10.1097/QAI.0000000000000337. J Acquir Immune Defic Syndr. 2014. PMID: 25197825
Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19).
Lakatos B, Kowalska J, Antoniak S, Gokengin D, Begovac J, Vassilenko A, Wasilewski P, Fleischhans L, Jilich D, Matulionyte R, Kase K, Papadopoulus A, Rukhadze N, Harxhi A, Hofman S, Dragovic G, Vasyliev M, Verhaz A, Yancheva N, Oprea C; Euroguideliness in Central and Eastern Europe (ECEE) Network Group. Lakatos B, et al. HIV Med. 2022 Jul;23(6):693-700. doi: 10.1111/hiv.13214. Epub 2021 Dec 3. HIV Med. 2022. PMID: 34859557
Transmitted drug resistance in newly diagnosed and treatment-naïve HIV type 1-infected patients in Hungary.
Áy É, Müller V, Mezei M, Pocskay Á, Koroknai A, Müller D, Győri Z, Marschalkó M, Tóth B, Kárpáti S, Lakatos B, Szlávik J, Takács M, Minárovits J. Áy É, et al. Among authors: lakatos b. J Glob Antimicrob Resist. 2020 Mar;20:124-130. doi: 10.1016/j.jgar.2019.07.014. Epub 2019 Jul 19. J Glob Antimicrob Resist. 2020. PMID: 31330377 Free article.
The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease-A report from Central and Eastern Europe.
Kowalska JD, Kase K, Vassilenko A, Harxhi A, Lakatos B, Lukić GD, Verhaz A, Yancheva N, Dumitrescu F, Jilich D, Machala L, Skrzat-Klapaczyńska A, Matulionyte R. Kowalska JD, et al. Among authors: lakatos b. Int J Infect Dis. 2021 Mar;104:293-296. doi: 10.1016/j.ijid.2020.12.026. Epub 2020 Dec 14. Int J Infect Dis. 2021. PMID: 33326871 Free PMC article.
Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck Ukraine.
Vasylyev M, Skrzat-Klapaczyńska A, Bernardino JI, Săndulescu O, Gilles C, Libois A, Curran A, Spinner CD, Rowley D, Bickel M, Aichelburg MC, Nozza S, Wensing A, Barber TJ, Waters L, Jordans C, Bramer W, Lakatos B, Tovba L, Koval T, Kyrychenko T, Dumchev K, Buhiichyk V, Smyrnov P, Antonyak S, Antoniak S, Vasylyeva TI, Mazhnaya A, Kowalska J, Bhagani S, Rokx C; European AIDS Clinical Society (EACS) Young Investigators (YING). Vasylyev M, et al. Among authors: lakatos b. Lancet HIV. 2022 Jun;9(6):e438-e448. doi: 10.1016/S2352-3018(22)00125-4. Epub 2022 May 13. Lancet HIV. 2022. PMID: 35576942 Review.
People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe - data from Euro-guidelines in Central and Eastern Europe Network.
Balayan T, Oprea C, Yurin O, Jevtovic D, Begovac J, Lakatos B, Sedlacek D, Karpov I, Horban A, Kowalska JD; Euro-guidelines in Central and Eastern Europe Network Group. Balayan T, et al. Among authors: lakatos b. Infect Dis (Lond). 2019 Apr;51(4):277-286. doi: 10.1080/23744235.2019.1565415. Epub 2019 Feb 21. Infect Dis (Lond). 2019. PMID: 30786803
Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary.
Szabo BG, Lenart KS, Petrik B, Gaspar Z, Kiss-Dala N, Szlavik J, Valyi-Nagy I, Lakatos B; Saint Ladislaus COVID-19 Collaborative. Szabo BG, et al. Among authors: lakatos b. Geroscience. 2021 Oct;43(5):2205-2213. doi: 10.1007/s11357-021-00452-9. Epub 2021 Sep 3. Geroscience. 2021. PMID: 34476717 Free PMC article.
Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study.
Senbayrak S, Ozkutuk N, Erdem H, Johansen IS, Civljak R, Inal AS, Kayabas U, Kursun E, Elaldi N, Savic B, Simeon S, Yilmaz E, Dulovic O, Ozturk-Engin D, Ceran N, Lakatos B, Sipahi OR, Sunbul M, Yemisen M, Alabay S, Beovic B, Ulu-Kilic A, Cag Y, Catroux M, Inan A, Dragovac G, Deveci O, Tekin R, Gul HC, Sengoz G, Andre K, Harxhi A, Hansmann Y, Oncu S, Kose S, Oncul O, Parlak E, Sener A, Yilmaz G, Savasci U, Vahaboglu H. Senbayrak S, et al. Among authors: lakatos b. Ann Clin Microbiol Antimicrob. 2015 Nov 4;14:47. doi: 10.1186/s12941-015-0107-z. Ann Clin Microbiol Antimicrob. 2015. PMID: 26538030 Free PMC article.
195 results